Antimalarial use and extra-renal damage accrual in lupus nephritis: a longitudinal cohort study
Abstract Objectives Antimalarial agents, particularly hydroxychloroquine, are fundamental in SLE management. While their renal benefits in lupus nephritis (LN) are recognized, their corresponding role in reducing extra-renal damage is less defined. This study examined the associ…